IVD Promotional/Advertising Reg Conflicts With First Amendment – Attorneys
This article was originally published in The Gray Sheet
Executive Summary
FDA-imposed restrictions on advertising and promotional materials for reagents used to manufacture in vitro diagnostics are particularly vulnerable to legal threats from industry, according to Hyman, Phelps & McNamara attorney Jeffrey Gibbs
You may also be interested in...
CDRH Reopens Analyte-Specific Reagent Rule, Expanding IVD Oversight
FDA will begin expanding oversight of homebrew in vitro diagnostics with a notice of proposed rulemaking on analyte-specific reagents in the coming weeks
CDRH Reopens Analyte-Specific Reagent Rule, Expanding IVD Oversight
FDA will begin expanding oversight of homebrew in vitro diagnostics with a notice of proposed rulemaking on analyte-specific reagents in the coming weeks
WLF Answers Democrats In First Amendment Off-Label Promotion Debate
Off-label information is not "inherently misleading," and consequently FDA should ease restrictions for disseminating it, the Washington Legal Foundation asserts in its response to congressional Democrats' interpretation of First Amendment case law